STRO - Sutro Biopharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

STRO is currently covered by 5 analysts with an average price target of $11.49. This is a potential upside of $9.56 (495.34%) from yesterday's end of day stock price of $1.93.

Sutro Biopharma's activity chart (see below) currently has 31 price targets and 48 ratings on display. The stock rating distribution of STRO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.24% with an average time for these price targets to be met of 225.29 days.

Highest price target for STRO is $17, Lowest price target is $8, average price target is $11.49.

Most recent stock forecast was given by RENI BENJAMIN from JMP on 11-Dec-2024. First documented stock forecast 22-Oct-2018.

Currently out of the existing stock ratings of STRO, 27 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$17

$15.12 (804.26%)

$17

14 days ago
(11-Dec-2024)

1/11 (9.09%)

$14.65 (623.40%)

24

Buy

$12

$10.12 (538.30%)

$12

1 months 7 days ago
(18-Nov-2024)

0/11 (0%)

$9.26 (337.96%)

Buy

$11

$9.12 (485.11%)

$12

2 months 14 days ago
(11-Oct-2024)

4/10 (40%)

$7.21 (190.24%)

402

Buy

$15

$13.12 (697.87%)

$25

4 months 9 days ago
(16-Aug-2024)

2/6 (33.33%)

$10.79 (256.29%)

172

Buy

$8

$6.12 (325.53%)

$8

7 months 11 days ago
(14-May-2024)

2/9 (22.22%)

$3.66 (84.33%)

708

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is STRO (Sutro Biopharma) average time for price targets to be met?

On average it took 225.29 days on average for the stock forecasts to be realized with a an average price target met ratio 29.24

Which analyst has the current highest performing score on STRO (Sutro Biopharma) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on STRO (Sutro Biopharma) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on STRO (Sutro Biopharma)?

Edward Tenthoff works at PIPER SANDLER and has 7 price targets and 6 ratings on STRO

Which analyst is the currently most bullish on STRO (Sutro Biopharma)?

Zhiqiang Shu with highest potential upside - $26.81

Which analyst is the currently most reserved on STRO (Sutro Biopharma)?

David Nierengarten with lowest potential downside - $6.12

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?